Dose Responsive Effects of Subcutaneous Pentosan Polysulfate Injection in Mucopolysaccharidosis Type VI Rats and Comparison to Oral Treatment

BACKGROUND: We previously demonstrated the benefits of daily, oral pentosan polysulfate (PPS) treatment in a rat model of mucopolysaccharidosis (MPS) type VI. Herein we compare these effects to once weekly, subcutaneous (sc) injection. The bioavailability of injected PPS is greater than oral, sugges...

Descripción completa

Detalles Bibliográficos
Autores principales: Frohbergh, Michael, Ge, Yi, Meng, Fanli, Karabul, Nesrin, Solyom, Alexander, Lai, Alon, Iatridis, James, Schuchman, Edward H., Simonaro, Calogera M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071040/
https://www.ncbi.nlm.nih.gov/pubmed/24964042
http://dx.doi.org/10.1371/journal.pone.0100882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071040/
https://www.ncbi.nlm.nih.gov/pubmed/24964042
http://dx.doi.org/10.1371/journal.pone.0100882

Ejemplares similares